Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adeno-associated virus serotype 9 antibody seroprevalence for patients in the United States with spinal muscular atrophy. | Mol Ther Methods Clin Dev | 2023 | 37822718 | PubTator, text mining | PubMed |
| Systematic Literature Review of the Natural History of Spinal Muscular Atrophy: Motor Function, Scoliosis, and Contractures. | Neurology | 2023 | 37813581 | PubTator, text mining | PubMed |
| Modified nusinersen intrathecal injection method: inclusion of a septal needle-free closed infusion connector. | Front Neurol | 2023 | 37808480 | PubTator, text mining | PubMed |
| Emerging roles of RNA binding proteins in intervertebral disc degeneration and osteoarthritis. | Orthop Surg | 2023 | 37803912 | PubTator, text mining | PubMed |
| Spinal muscular atrophy type I associated with a novel SMN1 splicing variant that disrupts the expression of the functional transcript. | Front Neurol | 2023 | 37799281 | PubTator, text mining | PubMed |
| Alternative splicing in lung influences COVID-19 severity and respiratory diseases. | Nat Commun | 2023 | 37794074 | PubTator, text mining | PubMed |
| Brazilian version of the CHOP INTEND scale: cross-cultural adaptation and validation. | Arq Neuropsiquiatr | 2023 | 37793404 | PubTator, text mining | PubMed |
| Innovating spinal muscular atrophy models in the therapeutic era. | Dis Model Mech | 2023 | 37787662 | PubTator, text mining | PubMed |
| Case report: A case of spinal muscular atrophy in a preterm infant: risks and benefits of treatment. | Front Neurol | 2023 | 37780708 | PubTator, text mining | PubMed |
| NADPH oxidase 4 inhibition is a complementary therapeutic strategy for spinal muscular atrophy. | Front Cell Neurosci | 2023 | 37780204 | PubTator, text mining | PubMed |
| Sleep disordered breathing in infants identified through newborn screening with spinal muscular atrophy. | Sleep Med | 2023 | 37778092 | PubTator, text mining | PubMed |
| Patient and Caregiver Outcomes After Onasemnogene Abeparvovec Treatment: Findings from the Cure SMA 2021 Membership Survey. | Adv Ther | 2023 | 37776479 | PubTator, text mining | PubMed |
| Neurologic orphan diseases: Emerging innovations and role for genetic treatments. | World J Exp Med | 2023 | 37767543 | PubTator, text mining | PubMed |
| Emerging Gene Therapy Approaches in the Management of Spinal Muscular Atrophy (SMA): An Overview of Clinical Trials and Patent Landscape. | Int J Mol Sci | 2023 | 37762045 | PubTator, text mining | PubMed |
| FexSplice: A LightGBM-Based Model for Predicting the Splicing Effect of a Single Nucleotide Variant Affecting the First Nucleotide G of an Exon. | Genes (Basel) | 2023 | 37761905 | PubTator, text mining | PubMed |
| Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases. | Biology (Basel) | 2023 | 37759656 | PubTator, text mining | PubMed |
| Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking. | Cells | 2023 | 37759475 | PubTator, text mining | PubMed |
| Daily Quantity and Kinematic Characteristics of Leg Movement in a Child With SMA (2 Copies SMN2). | Pediatr Phys Ther | 2023 | 37747987 | PubTator, text mining | PubMed |
| Sociodemographic and clinical characteristics and access to health care in patients with spinal muscular atrophy in Argentina. | Front Neurol | 2023 | 37745665 | PubTator, text mining | PubMed |
| Global impact of aberrant splicing on human gene expression levels. | bioRxiv | 2023 | 37745605 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=23